2,111 Followers on Owler

NAMSA

NAMSA is an Ohio-based contract research organization that provides product development, biological safety consulting and clinical research services for the medical industry. Read more

Christophe Berthoux's photo - CEO of NAMSA

CEO

Christophe Berthoux

CEO Approval Rating

82/100

Founded:

1967

Status:

NAMSA TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Missing a competitor? Contribute!

QPS is one of NAMSA's top competitors. QPS was founded in 1995, and its headquarters is in Newark, Delaware. Like NAMSA, QPS also works within the Medical Research & Laboratories sector. QPS has 200 more employees than NAMSA.

Clinipace is NAMSA's #2 rival. Clinipace was founded in 2003 in Morrisville, North Carolina. Clinipace operates in the Medical Research & Laboratories industry. Clinipace generates $28M less revenue than NAMSA.

CTI is a top competitor of NAMSA. CTI is a Private company that was founded in Covington, Kentucky in 1999. CTI is in the Medical Research & Laboratories field. CTI has 200 fewer employees vs. NAMSA.

Weigh-in!

Help the Owler community know more

Competitor - 1/1

Is Scientist a competitor of NAMSA?

NAMSA Acquisitions

COMPANY ACQUIRED
ACQUISITION DATE
AMOUNT
DESCRIPTION
American Preclinical Services, LLC

Mar 2021

Source »
undisclosed
APS is a preclinical CRO that provides analytics, biocompatibility testing and pathology services for the healthcare industry.
Syntactx, LLC

Jan 2021

Source »
undisclosed
Syntactx is a clinical research organization that offers clinical trials, medical device development, and regulatory consulting services.
Reimbursement Strategies, LLC

Jan 2019

Source »
undisclosed
Reimbursement Strategies is a consultancy firm that focuses on reimbursement, health economics and market access for the life science industry.
Namsa Medvance Ltd

Jan 2014

Source »
undisclosed
-
Alquest, LLC

Jan 2009

Source »
undisclosed
-

These are all the companies that NAMSA has acquired. NAMSA has acquired 6 companies and its latest acquisition was American Preclinical Services, LLC in Mar 2021. APS is a preclinical CRO that provides analytics, biocompatibility testing and pathology services for the healthcare industry.

NAMSA Funding History

Since NAMSA was founded in 1967, it has participated in 1 round of funding. In total NAMSA has raised $5.0M. NAMSA's funding round was on Apr 2020 for a total of $5.0M

ROUND

FUNDING DATE

AMOUNT

INVESTORS

Debt - PPP (CARES Act)
Apr 2020
$5M - $10M

U.S. Small Business Administration.

Since NAMSA was founded in 1967, it has participated in 1 round of funding. In total NAMSA has raised $5.0M. NAMSA's funding round was on Apr 2020 for a total of $5.0M

NAMSA Investments

No recent investments found related to NAMSA

These are all the companies that NAMSA has invested in. NAMSA has invested 6 companies and its latest investment was American Preclinical Services, LLC in Mar 2021. APS is a preclinical CRO that provides analytics, biocompatibility testing and pathology services for the healthcare industry.

NAMSA News

March 11, 2021StreetInsider

NAMSA Begins Next Chapter of Growth under Newly Appointed CEO, Dr. Christophe Berthoux

NAMSA®, the world’s only 100% medical device-focused Contract Research Organization (CRO) providing f... See more »
March 10, 2021Finance & Commerce

APS acquired by Toledo company

Toledo, Ohio-based NAMSA acquired American Preclinical Services, of Minneapolis, according to a news ... See more »
March 3, 2021Medical Design and Outsourcing

NAMSA acquires American Preclinical

Contract research organization NAMSA today announced its acquisition of Minneapolis-based American Pr... See more »
January 5, 2021Medical Device News Magazine

NAMSA Acquires Syntactx to Enhance End-to-End CRO Development Solutions, Expanding Medical Device Clinical Research Capabilities and Expertise

"Syntactx is very proud to join NAMSA, a long-recognized industry leader in CRO medical device develo... See more »
January 5, 2021PE Hub Network

ArchiMed-backed NAMSA buys Syntactx

NAMSA, which is backed by ArchiMed, has acquired Toledo, Ohio-based Syntactx, a contract research org... See more »
October 15, 2020Medical Buyer

ArchiMed acquires majority interest in NAMSA

Private equity healthcare specialist ArchiMed has acquired from the founding Gorski family a majority... See more »

NAMSA Blogs

June 9, 2020NAMSA Blog

IVD Clinical Trials in the Era of COVID-19: Time to go Virtual?

With the number of COVID-19 cases on the rise, and no definite end date to nationwide travel restrict... See more »
June 1, 2020NAMSA Blog

PharmTech Outlook: Cover Story Featuring NAMSA President & CEO, John Gorski

Over the last decade, the pharmaceutical and medical device industries have undergone significant tra... See more »
April 9, 2020NAMSA Blog

European Commission Mandate for EU Parliament Negotiations on MDR Delay: Clarification Regarding Article 120(3)

On 3 April 2020, NAMSA's EU Regulatory experts provided a critique of The European Commission's propo... See more »
April 9, 2020NAMSA Blog

European Commission Mandate for EU Parliament Negotiations on MDR delay: Clarification regarding Article 120(3)

On 3 April 2020, NAMSA's EU Regulatory experts provided a critique of The European Commission's propo... See more »
April 3, 2020NAMSA Blog

EU Response to COVID-19 Pandemic: Proposal to Delay Date of MDR Application to May 2021 for Certain Provisions

Countless industries are finding themselves under increased pressure throughout the global COVID-19 P... See more »
March 5, 2020NAMSA Blog

FDA Releases Final Guidance on Bone Anchor Premarket Notification 510(k) Submissions

This week's release of the U.S. Food and Drug Administration's (FDA) final guidance on "Bone Anchors ... See more »
March 5, 2020NAMSA Blog

FDA Releases Final Guidance on Bone Anchor Premarket Notification (510(k)) Submissions

This week's release of the U.S. Food and Drug Administration's (FDA) final guidance on "Bone Anchors ... See more »

NAMSA Press Releases

September 3, 2015MARKETWIRED

NAMSA and Fortuna Clinical Form Strategic Relationship

NORTHWOOD, OH--(Marketwired - September 03, 2015) - NAMSA, the world's leading medical research organ... See more »
April 1, 2015PR NEWSWIRE

MEDTEC & NAMSA Co-organize BPMDS Symposium China

SHANGHAI, April 1, 2015 /PRNewswire/ -- In what is a first formal tie-up for the two organizations, M... See more »

NAMSA Videos

Social Media

NAMSA Headquarters

6750 Wales Road

Northwood, Ohio43619

1-419-666-9455

Driving Directions »

Trending Companies

NAMSA Summary

ABOUT

Overview

NAMSA is an Ohio-based contract research organization that provides product development, biological safety consulting and clinical research services for the medical industry. NAMSA was founded in 1967. NAMSA's headquarters is located in Northwood, Ohi...

CEO

NAMSA's CEO, Christophe Berthoux, currently has an approval rating of 82%. NAMSA's primary competitors are QPS, Clinipace & CTI.

Website

namsa.com

Frequently Asked Questions about NAMSA

  1. When was NAMSA founded?

    NAMSA was founded in 1967
  2. Who is NAMSA's CEO?

    NAMSA's CEO is Christophe Berthoux
  3. How much revenue does NAMSA generate?

    NAMSA generates $150M in revenue
  4. How much funding does NAMSA have?

    NAMSA has historically raised $5M in funding
  1. Where is NAMSA's headquarters?

    NAMSA's headquarters is in Northwood Ohio, USA
  2. How many employees does NAMSA have?

    NAMSA has 1,000 employees
  3. What sector does NAMSA operate in?

    NAMSA is in Medical Research & Laboratories
  4. Who are NAMSA's competitors?

    NAMSA's top competitors are QPS, Clinipace, CTI